Progressive increase of resistance in Enterobacteriaceae urinary isolates from kidney transplant recipients over the past decade: narrowing of the therapeutic options

Transplant Infectious Disease

Volumn 18, Issue 4, 2016, Pages 575-584

  Origuen J ^a   Fernandez Ruiz M ^a   Lopez Medrano F ^a   Ruiz Merlo, T ^a   Gonzalez E ^a   Morales, J M ^a   Fiorante, S ^a   San Juan, R ^a   Villa, J ^a   Orellana, M A ^a   Andres A ^a   Aguado, J M ^a  

^a Universidad Complutense   (Spain)

Author keywords

antibiotic resistance; gram negative bacilli; kidney transplantation; urine culture; uropathogen

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; CEFAZOLIN; CEFEPIME; CEFOTAXIME; CEFUROXIME; CIPROFLOXACIN; COTRIMOXAZOLE; FOSFOMYCIN; GENTAMICIN; IMIPENEM; MEROPENEM; NITROFURANTOIN; PIPERACILLIN PLUS TAZOBACTAM;

ACUTE PYELONEPHRITIS; ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; ASYMPTOMATIC BACTERIURIA; BACTERIUM ISOLATE; CARBAPENEMASE PRODUCING ENTEROBACTERIACEAE; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ENTEROBACTERIACEAE; FEMALE; HUMAN; KIDNEY TRANSPLANTATION; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SINGLE DRUG DOSE; SPECIES DISTRIBUTION; STREPTOCOCCUS PNEUMONIA; URINARY TRACT INFECTION; URINE CULTURE;

EID: 84981250496     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/tid.12547     Document Type: Article

References (30)

1. Lorenz EC, Cosio FG. The impact of urinary tract infections in renal transplant recipients. Kidney Int 2010; 78: 719–721.
2. Vidal E, Torre-Cisneros J, Blanes M, et al. Bacterial urinary tract infection after solid organ transplantation in the RESITRA cohort. Transpl Infect Dis 2012; 14: 595–603.
3. Fiorante S, Fernández-Ruiz M, López-Medrano F, et al. Acute graft pyelonephritis in renal transplant recipients: incidence, risk factors and long-term outcome. Nephrol Dial Transplant 2011; 26: 1065–1073.
4. Azap O, Togan T, Yesilkaya A, Arslan H, Haberal M. Antimicrobial susceptibilities of uropathogen Escherichia coli in renal transplant recipients: dramatic increase in ciprofloxacin resistance. Transplant Proc 2013; 45: 956–957.
5. van Duin D, van Delden C; AST Infectious Diseases Community of Practice. Multidrug-resistant gram-negative bacteria infections in solid organ transplantation. Am J Transplant 2013; 13 (Suppl 4): 31–41.
6. Nicolle LE. Urinary tract infections in special populations: diabetes, renal transplant, HIV infection, and spinal cord injury. Infect Dis Clin North Am 2014; 28: 91–104.
7. Pelle G, Vimont S, Levy PP, et al. Acute pyelonephritis represents a risk factor impairing long-term kidney graft function. Am J Transplant 2007; 7: 899–907.
8. Green H, Rahamimov R, Gafter U, Leibovitci L, Paul M. Antibiotic prophylaxis for urinary tract infections in renal transplant recipients: a systematic review and meta-analysis. Transpl Infect Dis 2011; 13: 441–447.
9. Fiorante S, López-Medrano F, Lizasoain M, et al. Systematic screening and treatment of asymptomatic bacteriuria in renal transplant recipients. Kidney Int 2010; 78: 774–781.
10. Origüen J, López-Medrano F, Fernández-Ruiz M, et al. Should asymptomatic bacteriuria be systematically treated in kidney transplant recipients? Results from a randomized controlled trial. Am J Transplant 2016.doi: 10.1111/ajt.13829 [epub ahead of print].
11. Nicolle LE, Bradley S, Colgan R, et al. Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. Clin Infect Dis 2005; 40: 643–654.
12. Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012; 18: 268–281.
13. Cantón R, Alos JI, Baquero F, et al. [Recommendations for selecting antimicrobial agents for in vitro susceptibility studies using automatic and semiautomatic systems]. Enferm Infecc Microbiol Clin 2007; 25: 394–400.
14. Clinical and Laboratory Standards Institute (CLSI). Performance Standards of Antimicrobial Susceptibility Testing. CLSI Document M100-S24. Wayne, PA: Clinical and Laboratory Standards Institute (CLSI), 2014.
15. Brañas P, Villa J, Viedma E, Mingorance J, Orellana MA, Chaves F. Molecular epidemiology of carbapenemase-producing Klebsiella pneumoniae in a hospital in Madrid: successful establishment of an OXA-48 ST11 clone. Int J Antimicrob Agents 2015; 46: 111–116.
16. European Committee for Antimicrobial Susceptibility Testing (EUCAST). Breakpoint tables for interpretation of MICs and zone diameters (version 4.0). Available at: http://www.eucast.org (last accessed July 29, 2015).
17. Vuotto C, Longo F, Balice MP, Donelli G, Varaldo PE. Antibiotic resistance related to biofilm formation in Klebsiella pneumoniae. Pathogens 2014; 3: 743–758.
18. Lin WH, Kao CY, Yang DC, et al. Clinical and microbiological characteristics of Klebsiella pneumoniae from community-acquired recurrent urinary tract infections. Eur J Clin Microbiol Infect Dis 2014; 33: 1533–1539.
19. Strausbaugh LJ, Crossley KB, Nurse BA, Thrupp LD. Antimicrobial resistance in long-term-care facilities. Infect Control Hosp Epidemiol 1996; 17: 129–140.
20. Costelloe C, Metcalfe C, Lovering A, Mant D, Hay AD. Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis. BMJ 2010; 340: c2096.
21. Palou J, Pigrau C, Molina I, Ledesma JM, Angulo J; Grupo Colaborador Español del Estudio ARESC. [Etiology and sensitivity of uropathogens identified in uncomplicated lower urinary tract infections in women (ARESC Study): implications on empiric therapy]. Med Clin (Barc) 2011; 136: 1–7.
22. Sorlozano A, Jimenez-Pacheco A, de Dios Luna Del Castillo J, et al. Evolution of the resistance to antibiotics of bacteria involved in urinary tract infections: a 7-year surveillance study. Am J Infect Control 2014; 42: 1033–1038.
23. Broberg CA, Palacios M, Miller VL. Klebsiella: a long way to go towards understanding this enigmatic jet-setter. F1000Prime Rep 2014; 6: 64.
24. Brizendine KD, Richter SS, Cober ED, van Duin D. Carbapenem-resistant Klebsiella pneumoniae urinary tract infection following solid organ transplantation. Antimicrob Agents Chemother 2015; 59: 553–557.
25. Vidal E, Cervera C, Cordero E, et al. Management of urinary tract infection in solid organ transplant recipients: consensus statement of the Group for the Study of Infection in Transplant Recipients (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) and the Spanish Network for Research in Infectious Diseases (REIPI). Enferm Infecc Microbiol Clin 2015; 33 (10): 679.e1–679.e21.
26. Rodríguez-Baño J, Navarro MD, Retamar P, Picón E, Pascual Á. β-lactam/&beta-lactam inhibitor combinations for the treatment of bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli: a post-hoc analysis of prospective cohorts. Clin Infect Dis 2012; 54: 167–174.
27. Chuang P, Parikh CR, Langone A. Urinary tract infections after renal transplantation: a retrospective review at two US transplant centers. Clin Transplant 2005; 19: 230–235.
28. Cho YH, Jung SI, Chung HS, et al. Antimicrobial susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in health care-associated urinary tract infection: focus on susceptibility to fosfomycin. Int Urol Nephrol 2015; 47: 1059–1066.
29. Coussement J, Abramowicz D. Should we treat asymptomatic bacteriuria after renal transplantation? Nephrol Dial Transplant 2014; 29: 260–262.
30. Pouch SM, Kubin CJ, Satlin MJ, et al. Epidemiology and outcomes of carbapenem-resistant Klebsiella pneumoniae bacteriuria in kidney transplant recipients. Transpl Infect Dis 2015; 17 (6): 800–809.